The specific peptides in FORTIBONE® stimulate bone cells to increase the synthesis of bone components, including collagen. They counterbalance collagen degradation and influence degenerative processes in bones by reducing osteoclast activity, resulting in a higher synthesis of collagenous bone matrix.
Yes, a clinical study involving 180 women with reduced bone mass showed the potential of FORTIBONE®. The participants took 5g of FORTIBONE® or a placebo daily for 12 months. The study measured changes in bone mineral density (BMD) using DXA scans, and the results indicated a significant improvement in BMD after FORTIBONE® supplementation.
FORTIBONE® is beneficial for individuals with osteopenia or osteoporosis, particularly post-menopausal women who often experience bone atrophy and loss of bone density. However, it is also relevant for physically active individuals interested in maintaining good bone health.
FORTIBONE® can be used in various supplement formats, such as sachets, vials, gels, or functional foods. It provides options for creating innovative dietary supplements that promote bone health.
FORTIBONE® offers benefits such as a clean label (no E numbers), high digestibility, non-allergenic properties, and scientific evidence supporting its efficacy.
Yes, FORTIBONE® is non-allergenic and highly digestible, making it suitable for individuals with dietary restrictions or allergies.
As the producer of the active ingredient FORTIBONE®, GELITA does not recommend finished products/consumer goods in which our ingredients are found. We encourage you to search for products featuring our brand FORTIBONE® in common retail shops online and brick and mortar.